Array: Analysts Predict a Bright Future
Solar tracker giant Array got Buy ratings and $11 price targets. Focus on utility-scale and turnaround boosted confidence.
Already have an account? Sign in.
Solar tracker giant Array got Buy ratings and $11 price targets. Focus on utility-scale and turnaround boosted confidence.
Weltruza is the first monthly subcutaneous olanzapine for schizophrenia, with no loading dose and no post-shot clinic monitoring.
Targets imply 88% to 314% upside, with cash into 2027-2030.
Delta’s fuel bill is set to rise about $6 billion in 2026. The airline now guides adjusted earnings of $5.10–$5.60 a share, below July’s range.
Be the first to know when deals break, stocks move, or biotech headlines hit.